Tokutaro Miki

3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors

Satoshi Sogawa, Yasunori Nihro, Hiroki Ueda et al. · Journal of Medicinal Chemistry · 1993 · 98 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Inhibitory effects of 1-<i>O</i>-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[l,2-<i>a</i>: 3′ ,2′ -<i>d</i>]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-<i>f</i>]quinoxaline (MeIQx)

Masao Hirose, Ryohei Hasegawa, Juki Kimura et al. · Carcinogenesis · 1995 · 61 citations

Medicine, Pharmacology, Toxicology +16

Gastric Cytoprotective Anti-Ulcerogenic Actions of Hydroxychalcones in Rats

Kazunori Yamamoto, Hisao Kakegawa, Hiroki Ueda et al. · Planta Medica · 1992 · 56 citations

Medicine, Biochemistry, Pharmacology +12

Effects of 1‐O‐hexyl‐2,3,5‐trimethylhydroquinone on carbon tetrachloride‐induced hepatic cirrhosis in rats

Jun An, Guo‐Gang Feng, Lei Huang et al. · Hepatology Research · 2010 · 45 citations

Medicine, Pharmacology, Toxicology +17

Stage and organ dependent effects of 1-O-hexyl-2,3,5-trimethylhydroquinone, ascorbic acid derivatives, N-heptadecane-8,10-dione and phenylethyl isothiocyanate in a rat multiorgan carcinogenesis model

Kumiko Ogawa, Mitsuru Futakuchi, Masao Hirose et al. · International Journal of Cancer · 1998 · 39 citations

Pharmacy, Pharmacology, Toxicology +12